INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 84 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 2.41 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $259,026,930 | -22.4% | 8,191,870 | +0.1% | 0.01% | -25.0% |
| Q2 2023 | $333,790,457 | +10.1% | 8,185,151 | +0.6% | 0.01% | 0.0% |
| Q1 2023 | $303,108,637 | +11.2% | 8,132,778 | +4.1% | 0.01% | +14.3% |
| Q4 2022 | $272,498,785 | -26.4% | 7,810,226 | +18.0% | 0.01% | -36.4% |
| Q3 2022 | $370,305,000 | +9.9% | 6,617,323 | +1.7% | 0.01% | +22.2% |
| Q2 2022 | $336,920,000 | -27.5% | 6,509,282 | +1.8% | 0.01% | -18.2% |
| Q1 2022 | $464,502,000 | -39.0% | 6,391,940 | -0.8% | 0.01% | -35.3% |
| Q4 2021 | $761,744,000 | -10.6% | 6,442,355 | +1.4% | 0.02% | -19.0% |
| Q3 2021 | $852,299,000 | -12.6% | 6,353,334 | +5.4% | 0.02% | -12.5% |
| Q2 2021 | $975,698,000 | +117.9% | 6,026,177 | +8.0% | 0.02% | +100.0% |
| Q1 2021 | $447,722,000 | +60.4% | 5,578,744 | +8.7% | 0.01% | +50.0% |
| Q4 2020 | $279,137,000 | +220.8% | 5,131,197 | +17.2% | 0.01% | +166.7% |
| Q3 2020 | $87,010,000 | -2.8% | 4,376,799 | +2.8% | 0.00% | 0.0% |
| Q2 2020 | $89,486,000 | +109.8% | 4,257,196 | +22.0% | 0.00% | +50.0% |
| Q1 2020 | $42,661,000 | -17.5% | 3,488,249 | -1.0% | 0.00% | 0.0% |
| Q4 2019 | $51,701,000 | +12.2% | 3,524,199 | +2.1% | 0.00% | 0.0% |
| Q3 2019 | $46,092,000 | -11.6% | 3,452,461 | +8.4% | 0.00% | 0.0% |
| Q2 2019 | $52,124,000 | +8.5% | 3,184,116 | +13.2% | 0.00% | 0.0% |
| Q1 2019 | $48,035,000 | +28.1% | 2,812,392 | +2.4% | 0.00% | 0.0% |
| Q4 2018 | $37,485,000 | -50.6% | 2,746,126 | +3.5% | 0.00% | -33.3% |
| Q3 2018 | $75,934,000 | +17.3% | 2,653,165 | +12.2% | 0.00% | 0.0% |
| Q2 2018 | $64,720,000 | +52.7% | 2,365,483 | +17.7% | 0.00% | +50.0% |
| Q1 2018 | $42,381,000 | +20.1% | 2,009,513 | +9.4% | 0.00% | 0.0% |
| Q4 2017 | $35,297,000 | +35.9% | 1,836,481 | +75.7% | 0.00% | +100.0% |
| Q3 2017 | $25,976,000 | +62.8% | 1,045,293 | +4.8% | 0.00% | 0.0% |
| Q2 2017 | $15,957,000 | +25.2% | 997,288 | +10.2% | 0.00% | 0.0% |
| Q1 2017 | $12,747,000 | +11.7% | 904,708 | +3.9% | 0.00% | 0.0% |
| Q4 2016 | $11,416,000 | +52.6% | 870,783 | +98.1% | 0.00% | – |
| Q3 2016 | $7,483,000 | -15.9% | 439,630 | +5.5% | 0.00% | -100.0% |
| Q2 2016 | $8,894,000 | – | 416,564 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,216,340 | $62,958,000 | 7.04% |
| Discovery Value Fund | 584,483 | $30,253,000 | 6.33% |
| MPM BioImpact LLC | 299,409 | $15,497,000 | 4.30% |
| ARK Investment Management | 9,514,580 | $439,003,000 | 2.60% |
| Elmwood Wealth Management, Inc. | 67,899 | $3,514,000 | 2.00% |
| Nikko Asset Management Americas, Inc. | 2,781,136 | $141,143,000 | 1.74% |
| Avidity Partners Management LP | 1,125,194 | $58,240,000 | 1.34% |
| Merlin Capital, Inc | 12,174 | $630,000 | 1.26% |
| Atlas Venture Associates IX, LLC | 10,000 | $518,000 | 1.18% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $5,768,000 | 1.16% |